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Conclusion: For a particular drug, contraindications and method 
of administration comprise most of the essential ready knowledge. 
Other aspects include only common side effects, basic mechanism of 
action, and standard adult dosage. Little knowledge about interac­
tions was identified as being essential. Junior doctors seem to have 
inadequate ready knowledge essential to good prescribing. Ready 
knowledge about mechanism of action and the major categories con­
traindications and method of administration is lacking most. This 
might be an indication to improve pharmacotherapeutical education 
on these aspects.
1. Farmacotherapeutisch Kompas 2012, College van Zorgverze­
keringen.
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Introduction: Medical students should be better prepared for their 
future role as therapeutic prescribers, to reduce medical errors and 
health costs. Context­based learning is widely known for its positive 
effects on learners; however, the extent to which context learning is 
applied in different pharmacotherapy­curricula varies. The optimal 
and most realistic form of context learning in pharmacotherapy edu­
cation would be learning (to prescribe) in a learner­centered student 
run clinic (LC­SRC). In contrast to regular student­run clinics (SRCs), 
which are clinics organized and run by student­teams who mainly 
care for the underserved and homeless populations in the United 
States, LC­SRCs do not exist. In advance of our plans to start a 
LC­SRC, we aim to analyze student outcomes of (regular) SRCs on 
skills, knowledge, and attitudes.
Patients (or Materials) and Methods: A systematic literature review 
according to the PRISMA guidelines in the PubMed and ERIC 
databases was performed. Additionally, we used the SNOWBALL 
method, checking all references in included articles.
Results: Pubmed and ERIC database search yielded 205 unique hits; 
upon further analysis, 59 articles were on SRCs and 24 (41%) of 
this articles reported outcomes on students’ skills, knowledge, or 
attitudes. Only 5 articles (21%) had a (quasi­)experimental design, 1 
“non­experimental” article was a literature review. Overall strength 
of findings was rated mean 2.56 on a 5­point scale. Snowball search 
of 865 references yielded 52 new hits, de­doubled 27 unique new 
articles on SRCs. The effect of participation of medical students’ 
skills, knowledge, and attitudes in SRCs is uncertain, mainly based 
on expert opinions and student surveys. Students report improved 
skills (ie, in history taking and physical examination), indicated they 
obtained knowledge they were unlikely to get elsewhere and valued 
the SRC as educationally relevant.
Conclusion: Quality of research on student participation outcomes 
is poor, research design is often inferior (observational not (quasi­)
experimental), methods are poorly described, follow­up time if 
done is short, and conclusions could often not be based on results. 
Considering the theoretical benefits and the lack of evidence of stu­
dent outcomes on participation in SRCs, further research should 
be performed. The best location for such research would be at a 
LC­SRC. The goal should be to gather conclusive evidence on learner 
outcomes. This highly promising concept could contribute to optimal 
context­based learning, improving pharmacotherapy education. Our 
results of the first evaluation of our pilot LC­SRC from March 2013 ­ 
June 2013 will be presented at the EACPT congress
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Introduction: Teaching in clinical pharmacology for students in 
medicine and biomedical disciplines is often focused on theory, while 
practical courses, which can introduce methods of research and clini­
cal application to students, are underrepresented.
Patients (or Materials) and Methods: We adapted a saliva­based, 
noninvasive CYP1A2 phenotyping protocol to the needs of an after­
noon practical course for third­year biomedical sciences students. 
Those students who freely decided to quantify their own CYP1A2 
activity had to abstain from caffeine sources starting from the even­
ing before the course day. In the morning, students collected a saliva 
sample at home into a tube, which was handed out together with the 
course documentation some days before the course. Thereafter, they 
drank a cup of strong coffee, black tea, or caffeinated energy drinks 
and abstained from caffeine until the collection of the second saliva 
sample at the course site in the early afternoon, 5 to 6 hours after 
caffeine intake. The students then prepared their own saliva samples 
for the quantification of caffeine and paraxanthine using a published 
HPLC­UV method. The run­time per sample was 18 minutes, so that 
in the end of the afternoon, the evaluation of a limited calibration 
curve and the caffeine­to­paraxanthine clearances of 2 participants 
was possible. Clearance values were estimated using a published for­
mula that translates the paraxanthine and caffeine concentrations to 
clearance values.
Results: Between 11 and 20 students participated per year in groups 
to 3 of 5 students. As expected, metabolic caffeine clearance was 
accelerated in smokers (2.18 mL/min/kg body weight; coefficient of 
variation, 61%) compared with nonsmokers (1.37 mL/min/kg body 
weight; coefficient of variation, 83%). Students’ satisfaction with the 
practical course was good.
Conclusion: The students got an estimate of their own phenotypic 
CYP1A2 activity and an impression of the interindividual variability 
in xenobiotic metabolism, in particular of the influence of smoking 
on CYP1A2 activity. As an advantage, no drug was used for this 
test. Additionally, students acquired knowledge of drug analysis and 
methods applied in clinical pharmacology.
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Introduction: Undergraduate pharmacotherapy teaching has to deal 
with the following facts. [1] Every practicing physician should be 
able to use medicines properly, taking into account important non­
pharmacologic aspects like drug adherence and treatment cost. [2] 
Knowledge taught to students is often already outdated at the time 
they graduate. [3] Often not 1 therapy is correct but > 1 therapeu­
tic option is defendable. [4] Guidelines show first­choice treatments 
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suitable for the majority of patients but not per se for the individual 
consulting patient.
Patients (or Materials) and Methods: Based on these challenges, 
emphasis of the course is put on attitude training. The good manage­
ment of a specific disease/condition comes in second line and is pri­
marily a way for attitude training. The main attitudes to learn are: [1] 
how to choose the most suitable drug for a target condition and [2] 
how to accommodate this choice to the individual patient? Students 
are trained in choosing drugs according to the “WHO guide to good 
prescribing’’ and in doing a consultation in a systematic way (the 
6­step approach). Key steps are the therapeutic goals and to check 
whether the first­choice treatment in the formulary/guideline would 
be suitable for the individual patient. The course consists of plenary 
lectures and tutorials prepared by homework. The expert clinician 
is asked to provide the knowledge of the diseases and therapeutic 
management during the plenary lectures. Tutorials are organized by 
the pharmacotherapy task force (PTF) in small groups (of ~15 stu­
dents) with the aim to analyze and process the patient cases using 
the 6­step approach. Pharmacotherapeutic competence is tested in a 
separate competence exam.
Results: Threats and opportunities for implementation: [1] Not all 
pharmacotherapy taught by expert clinicians was evidence based. 
This led to discussions with clinicians to implement evidence­based 
pharmacotherapy. When evidence for a treatment is poor or even 
absent, different schools may teach their own “expert opinion.” This 
is also explained to students and examples are given. [2] Not all teach­
ers were convinced of the utility of competence teaching and refused 
to participate or even disturbed the implementation. Therefore, a 
group of interested tutors has been trained in competence teaching, 
the PTF. [3] Students’ workload increased by the homework. Some 
students scored the pharmacotherapy tutorials very low, hoping to get 
rid of this extra homework. These complaints largely disappeared in 
the last year or during internships, when trained competences could 
be used in practice.
Conclusion: Students regularly get positive feedback from their train­
ers during internships and Erasmus exchanges about their acquired 
competence in pharmacotherapy.
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Introduction: There is global concern about the quality of prescrib­
ing training in medical schools and the rational prescribing skills of 
junior doctors. In the Faculty of Health Sciences, University of the 
Witwatersrand, curricular change sought to reduce the factual burden 
of learning and enhance evaluative capacities through the introduc­
tion of an integrated syllabus delivered via problem­based learning
Patients (or Materials) and Methods: Members of the graduating 
class of 2008 in the Faculty of Health Sciences, University of the 
Witwatersrand, were invited to participate in a directly administered 
cross­sectional survey using an Internet­administered questionnaire 
(assuring anonymous responses) through the Centre for Health 
Science Education (CHSE) electronic class noticeboard. In addition, 
their exit­level examination results were made available to calculate 
a “prescribing competence” mark.
Results: Despite the new curriculum, graduating students reported 
a lack of confidence to prescribe. To explore this finding, this paper 
analyzes prescribing competence in relation to Bernstein’s theoretical 
framework of the structure of knowledge. Prescribing is described 
as a regionalized skill in relation to several singular disciplines. For 
successful students, the disciplinary knowledge base necessary for 
rational prescribing decisions is a Bernsteinian vertical discourse with 
conceptual coherence. Other students, however, cannot distinguish 
beyond the context of each clinical problem presented, and their 
resultant learning is segmented and not transferrable. In addition, 
this contextual learning leads to a subjective increase in volume, since 
disciplinary knowledge is not incorporated into inclusive principles.
Conclusion: Thus, curricular components including problem­based 
learning and horizontal integration constrain epistemic access to the 
structure of rational prescribing knowledge for some students.
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Introduction: Drug fever is a disorder characterized by a febrile 
response coinciding temporally with the administration of drug in the 
absence of any other conditions that may cause the fever. It is impor­
tant for clinicians to suspect drugs as a cause of fevers of unknown 
origin because failure of prompt diagnosis can lead to prolonged 
hospital stay. Here we illustrate a case of drug­induced fever.
Patients (or Materials) and Methods: A 45­year­old woman had 
intermittent fever after an elective revision of her right knee hemiar­
throplasty. The initial suspicion was a partially treated septic arthri­
tis, and she was treated with a prolonged course of intravenous 
teicoplanin and oral rifampicin. Her fever persisted despite antibiot­
ics, prompting referral to our department.
Physical examination revealed a disproportionately well woman 
who was febrile (38.5). All her investigations showed no evidence of 
infection. After 5 days of antibiotic treatment, she remained febrile 
with a high C­reactive protein levels. The possibility of drug fever due 
to teicoplanin and/or rifampicin was discussed, and both drugs were 
discontinued. Upon discontinuation, her fever returned to normal 
and C­reactive protein levels normalized.
Results: Drug fever may have any pattern. The fever typically resolves 
within 48 to 72 hours, depending on the agent, its elimination rate, 
and the patient’s comorbidities. The single consistent characteristic 
of drug fever is the resolution of the fever when the responsible agent 
is stopped. In our case, the possibility of drug fever was considered 
because the patient appeared disproportionately well and was not 
mounting a tachycardic response to an infective process. Septic arthri­
tis was excluded with a negative synovial fluid aspirate. Endocarditis 
was excluded with a negative trans­thoracic echocardiogram. Blood 
culture and urine culture did not grow anything. Persistence of drug 
fever by teicoplanin has been described in various case reports. The 
fever occurred at doses of 0.12 mg/d and is prolonged with the long 
half­life of teicoplanin. Rifampicin is less likely to cause fever.
Conclusion: Drug fever is a common but often overlooked condition. 
Prompt diagnosis is important as it can obviate expensive diagnostic 
workup and inappropriate use of antimicrobial agents. It should be 
considered in cases when the patient is disproportionately well with 
no clear source of infection.
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